Blood thinner patients get at-home test
People on Coumadin may need fewer doctor's visits
March 13, 1997
Web posted at: 11:10 p.m. EST
(CNN) -- Some patients who take a commonly prescribed blood
thinner may be able to skip frequent doctor visits, thanks to
a new system that lets them monitor their dosage at home.
About 1.8 million Americans take the drug Coumadin for
medical conditions such as heart attacks. On Thursday, the
Food and Drug Administration approved a testing system called
ProTime that will let Coumadin patients check their blood at
home to insure that they are taking the proper dosage.
Too much Coumadin can cause nosebleeds and more serious
complications; too little may result in a blood clot. Until
now, patients had to be closely monitored, because the drug
interacts with some foods, alcohol and over-the-counter
drugs. That meant frequent visits to the doctor.
But one Coumadin expert, Dr. Raymond Woosley of Georgetown
University, said although doctors have long wanted an at-home
testing device, the cost of the ProTime system -- $2,000 --
may "markedly limit the value of it."
International Technidyne Corp., which makes ProTime,
estimates that about 30 percent of patients on Coumadin are
at high enough risk for complications to benefit from home
testing. The company is negotiating with Medicare and
insurance companies to pay for the device.
The Associated Press contributed to this report.
Related sites:
© 1997 Cable News Network, Inc.
All Rights Reserved.